FIELD: medicine.
SUBSTANCE: invention relates to medicine; it can be used for the treatment of a tumor condition in a subject. A reduced lyophilized composition for deamination of asparagine is claimed, which contains polyalkylene oxide-asparaginase at a concentration from 100 to 5000 IU/ml of the specified composition, sodium dibasic phosphate at a concentration from 0.1 to 0.8 wt. % , monobasic sodium phosphate in a concentration from 0.01 to 0.5 wt. % , salt in a concentration from 0.05 to 1 wt. % and sugar in a concentration from 0.1 to 25 wt. %, where polyalkylene oxide-asparaginase contains asparaginase covalently bound to a polyalkylene oxide group. A lyophilized storage-stable composition for deamination of asparagine is stable during storage and is capable of forming a reduced lyophilized storage-stable composition, when reduced with water for injection (WFI). A method for preparing a lyophilized composition of polyalkylene oxide-asparaginase includes lyophilization of an aqueous concentrate of a composition containing: (I) polyalkylene oxide-asparaginase containing a polyalkylene oxide group covalently bound to asparaginase by a linker; (II) a buffer containing sodium dibasic phosphate and sodium monobasic phosphate; (III) salt and (III) sugar. An asparagine deamination kit contains one or more containers with single doses, each containing a lyophilized storage-stable composition.
EFFECT: compositions are used for various applications, for example, for the treatment of a tumor condition in a subject.
18 cl, 32 tbl, 16 dwg, 3 ex
Title | Year | Author | Number |
---|---|---|---|
THERAPEUTIC TARGETED FUSION PROTEINS BASED ON LYSOSOMAL ENZYMES, RELEVANT COMPOSITIONS AND THEIR APPLICATIONS | 2017 |
|
RU2751235C2 |
PHARMACEUTICAL COMPOSITIONS OF ERYTHROPOIETIN | 2000 |
|
RU2225221C2 |
VACCINE COMPOSITIONS | 2010 |
|
RU2581020C2 |
PHARMACEUTICAL COMPOSITIONS FOR TREATING ACID SPHINGOMYELINASE DEFICIENCY | 2019 |
|
RU2826120C2 |
COMPOSITIONS AND METHODS FOR TREATING VISUAL ORGAN DISORDERS | 2018 |
|
RU2761436C1 |
PHARMACEUTICAL COMPOSITIONS WITH IL-2 | 2016 |
|
RU2783864C2 |
FORMULATIONS WITH ADENO-ASSOCIATED VIRUS | 2017 |
|
RU2769196C2 |
METHOD FOR INTRODUCING EPOTILONE ANALOGS FOR TREATING CANCER CASES | 2002 |
|
RU2292202C2 |
PNEUMOCOCCAL POLYSACCHARIDES AND THEIR USE IN IMMUNOGEN POLYSACCHARIDE-PROTEIN-CARRIER CONJUGATES | 2018 |
|
RU2785429C2 |
POWDER CONTAINING BUFFER SALT AND AMINO ACID, DISSOLUTION OF SUCH POWDER TO NUTRIENT PRODUCT AND METHODS OF USE OF SUCH NUTRIENT PRODUCT | 2019 |
|
RU2810755C2 |
Authors
Dates
2021-11-01—Published
2017-06-01—Filed